These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 626809)

  • 41. Newer contrast agents for urography.
    Spataro RF
    Radiol Clin North Am; 1984 Jun; 22(2):365-80. PubMed ID: 6205415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iopamidol: new preclinical and clinical data.
    Bonati F; Felder E; Tirone P
    Invest Radiol; 1980; 15(6 Suppl):S310-6. PubMed ID: 7203941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excretion of metrizamide. II. An experimental investigation in rabbit, rat and cat after intravenous, suboccipital and peroral administration of 125I-labelled metrizamide.
    Golman K
    Acta Radiol Suppl; 1973; 335():258-63. PubMed ID: 4534563
    [No Abstract]   [Full Text] [Related]  

  • 45. Radiopaque contrast media. XLVI - Preliminary studies of the metabolism of iopamidol in the dog, the rabbit and man.
    Pitrè D; Tirone P; Viviani G
    Farmaco Sci; 1980 Oct; 35(10):826-35. PubMed ID: 7450018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excretion of aqueous myelographic contrast media in animals undergoing a repeat myelogram.
    Eldevik OP; Haughton VM; Sasse EA; Ho KC
    Invest Radiol; 1980; 15(6):507-10. PubMed ID: 7203906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metrizamide in experimental urography. III. Effects of temporary ureteric stasis on urinary iodine concentration after intravenous injection of ionic and non-ionic contrast media.
    Almén T; Härtel M; Golman K
    Acta Radiol Suppl; 1973; 335():330-8. PubMed ID: 4534572
    [No Abstract]   [Full Text] [Related]  

  • 48. Urographic excretion studies with nonionic contrast agents. Iopamidol vs. iothalamate.
    Wilcox J; Evill CA; Sage MR; Benness GT
    Invest Radiol; 1983; 18(2):207-10. PubMed ID: 6862812
    [No Abstract]   [Full Text] [Related]  

  • 49. Toxicity of X-ray contrast media in cell cultures.
    Kormano M; Frey H
    Invest Radiol; 1980; 15(1):68-71. PubMed ID: 7353945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of low-osmolality contrast media on red cell filterability.
    Imai H; Hiruma H; Kumazaki T; Uyesaka N
    Acta Radiol; 1993 May; 34(3):214-9. PubMed ID: 8489832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monomer-dimer contrast media in the renal circulation: experimental angiography.
    Russell SB; Sherwood T
    Br J Radiol; 1974 May; 47(557):268-71. PubMed ID: 4830150
    [No Abstract]   [Full Text] [Related]  

  • 52. Metabolism of urographic contrast media.
    Kelly M; Golman K
    Invest Radiol; 1981; 16(2):159-64. PubMed ID: 7216706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urographic contrast agents. Comparison of sodium and methylglucamine salts of iothalamate monomer and dimer.
    Benness GT; Glazer M
    Clin Radiol; 1973 Oct; 24(4):445-8. PubMed ID: 4621054
    [No Abstract]   [Full Text] [Related]  

  • 54. Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.
    Fike JR; Cann CE; Norman D; Turrel JM; LeCouteur RA; Pflugfelder CM; Borcich JK
    AJNR Am J Neuroradiol; 1984; 5(4):413-7. PubMed ID: 6431776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metrizamide in experimental urography. I. Iodine concentration and flow of urine following intravenous injection of an ionic and non-ionic contrast medium in rabbits.
    Golman K; Almén T
    Acta Radiol Suppl; 1973; 335():312-22. PubMed ID: 4534570
    [No Abstract]   [Full Text] [Related]  

  • 56. Arachnoiditis following myelography with water-soluble agents. The role of contrast medium osmolality.
    Haughton VM; Ho KC; Unger GF
    Radiology; 1977 Dec; 125(3):731-3. PubMed ID: 412226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The correlation between radiographic appearance and contrast excretion during infusion urography with dissimilar renal function (author's transl)].
    Bahlmann J; Holsten D
    Fortschr Geb Rontgenstr Nuklearmed; 1974 Jun; 120(6):686-91. PubMed ID: 4368279
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of an ionic low-osmolality contrast medium (ioxaglate) on the erythrocyte membrane].
    Okada S; Asahi R; Tajima N; Kumazaki T; Hasegawa S; Kikuchi H; Uyesaka N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 May; 47(5):729-44. PubMed ID: 3658660
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of renal function before and after intravenous injection of uroangiographic water soluble contrast media in men.
    Verbaeys A; Lameire N; Oosterlinck W
    Acta Urol Belg; 1989; 57(4):795-801. PubMed ID: 2631582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium.
    Bakris GL; Gaber AO; Jones JD
    Radiology; 1990 Apr; 175(1):57-60. PubMed ID: 2315505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.